Cutaneous perforating disorders
| Cutaneous perforating disorders | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Skin lesions, itching, pain |
| Complications | Infection, scarring |
| Onset | Varies by type |
| Duration | Chronic |
| Types | Kyrle disease, Reactive perforating collagenosis, Elastosis perforans serpiginosa, Perforating folliculitis |
| Causes | Genetic factors, trauma, metabolic disorders |
| Risks | Diabetes mellitus, chronic renal failure |
| Diagnosis | Clinical examination, biopsy |
| Differential diagnosis | Psoriasis, lichen planus, eczema |
| Prevention | N/A |
| Treatment | Topical corticosteroids, retinoids, keratolytics |
| Medication | |
| Prognosis | Variable, often chronic |
| Frequency | Rare |
| Deaths | N/A |
Cutaneous perforating disorders are a group of skin conditions characterized by the transepidermal elimination of dermal material. The disorders are classified into four main types: Kyrle disease, Reactive perforating collagenosis, Elastosis perforans serpiginosa, and Perforating folliculitis.
Classification[edit]
Cutaneous perforating disorders are classified into four main types:
- Kyrle disease - This is a rare, acquired, perforating dermatosis that is characterized by hyperkeratotic papules and nodules, which are often located on the lower extremities.
- Reactive perforating collagenosis - This is a rare form of transepidermal elimination in which altered collagen is extruded through the epidermis. It can occur in both inherited and acquired forms.
- Elastosis perforans serpiginosa - This is a rare skin disorder where connective tissue and elastic tissue is viewed as foreign material and is eliminated from the body through the skin.
- Perforating folliculitis - This is a condition characterized by the transepidermal elimination of keratin through the hair follicles.
Symptoms[edit]
The symptoms of cutaneous perforating disorders vary depending on the specific type of disorder. However, common symptoms include skin lesions, itching, and in some cases, a secondary infection due to scratching or picking at the lesions.
Causes[edit]
The exact cause of cutaneous perforating disorders is unknown. However, they are often associated with systemic diseases such as diabetes mellitus, chronic kidney disease, and liver disease. Some forms of the disorder are also thought to be genetic.
Treatment[edit]
Treatment for cutaneous perforating disorders typically involves managing the symptoms and any underlying conditions. This may include the use of topical creams, oral medications, and in some cases, light therapy.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian